• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    More On RNA

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    BioMarin Nederland B.V. (RNA)

    -NasdaqGS
    0.00 0.00(0.00%) N/A
    Add to Portfolio
    Prev Close:N/A
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:16.51
    Beta:3.866
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:6.00 - 22.80
    Volume:0
    Avg Vol (3m):77,661
    Market Cap:0.00
    P/E (ttm):N/A
    EPS (ttm):-1.34
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in .

    Comparison

    Symbol% ChgMkt Cap
    RNA 0.00%0.00
    PTCTDown 0.02%1.62B
    SRPTUp 1.31%1.25B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (Dec-14) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioMarin Nederland B.V., a biotechnology company, engages in the discovery and development of ribonucleic acid-modulating therapeutics for the treatment of genetic disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback